Showing results (891-900 of 964) with videos related to

Sort By:
Pageof 97
Allergy|April 21, 2026
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task ForceSophie Scheire, Evelijn Lourijsen, Manon Blauwblomme, et al.
The International Journal on Drug Policy|November 2, 2018
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapyJason Grebely, Brian Conway, Evan B Cunningham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2018
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular CarcinomaHo Yeong Lim, Philippe Merle, Karl Heinz Weiss, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2026
Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis BCong Cheng, Qing Xie, Edward Gane, et al.
The International Journal on Drug Policy|October 24, 2018
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY studyEvan B Cunningham, Janaki Amin, Jordan J Feld, et al.
Genome Biology|January 28, 2012
A genome triplication associated with early diversification of the core eudicotsYuannian Jiao, Jim Leebens-Mack, Saravanaraj Ayyampalayam, et al.
Journal of Hepatology|June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisSergio M Borgia, Janet Dearden, Eric M Yoshida, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2019
Evolution of chloroplast retrograde signaling facilitates green plant adaptation to landChenchen Zhao, Yuanyuan Wang, Kai Xun Chan, et al.
The Lancet. Gastroenterology & Hepatology|January 10, 2018
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trialJason Grebely, Olav Dalgard, Brian Conway, et al.
International Forum of Allergy & Rhinology|May 9, 2025
The Development and Validation of the Smell-Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory DisordersMatt Lechner, Alexander Fjaeldstad, Umar Rehman, et al.
Pageof 97